Bisphosphonates et ostéonécrose maxillomandibulaire

Cheng, 2005, The dental implications of bisphosphonates and bone disease, Aust Dent J, 50, S4, 10.1111/j.1834-7819.2005.tb00384.x Leite, 2006, Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review, Oral Surg Oral Pathol Oral Radiol Endod, 102, 14, 10.1016/j.tripleo.2005.10.045 Woeller, 2006, Ostéonécrose des maxillaires sous bisphosphonates : cinq cas, Rev Stomatol Chir Maxillofac, 107, 417, 10.1016/S0035-1768(06)77080-2 Nastro, 2007, Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer, Acta Haematol, 117, 181, 10.1159/000097876 Marx, 2003, Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic, J Oral Maxillofac Surg, 61, 1115, 10.1016/S0278-2391(03)00720-1 Ruggiero, 2004, Osteonecrosis of the jaws associated with use of biphosphonates: a review of 63 cases, J Oral Maxillofac Surg, 62, 527, 10.1016/j.joms.2004.02.004 Ortega, 2007, Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis, Acta Oncol, 46, 664, 10.1080/02841860601185917 Dimopoulos, 2006, Osteonecrosis of the jaw in patient with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid, Haematologica, 91, 968 Mavrokokki, 2007, Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia, J Oral Maxillofac Surg, 65, 415, 10.1016/j.joms.2006.10.061 Mortensen, 2007, Osteonecrosis of the jaw associated with bisphosphonate use: presentation of seven cases and literature review, Laryngoscope, 117, 30, 10.1097/01.mlg.0000240885.64568.9e Yarom, 2007, Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome, Osteoporos Int, 18, 1363, 10.1007/s00198-007-0384-2 Wang, 2007, Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy, J Oral Maxillofac Surg, 65, 1328, 10.1016/j.joms.2007.03.006 Magopoulos, 2007, Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals, Am J Otolaryngol, 28, 158, 10.1016/j.amjoto.2006.08.004 Mignogna, 2006, Osteonecrosis of the jaws associated with bisphosphonate therapy, J Clin Oncol, 24, 1475, 10.1200/JCO.2005.01.7756 Dimitrakopoulos, 2006, Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases, Int J Oral Maxillofac Surg, 35, 588, 10.1016/j.ijom.2006.02.022 Van den Wyngaert, 2006, Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post-hoc fallacy?, Ann Oncol, 17, 1197, 10.1093/annonc/mdl294 Ficarra, 2005, Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment, J Clin Periodontol, 32, 1123, 10.1111/j.1600-051X.2005.00842.x Pozzi, 2007, Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients, Leuk Lymphoma, 48, 56, 10.1080/10428190600977690 Nagai, 2007, Antiangiogenic effects of bisphosphonates on laser-induced choroidal neovascularization in mice, Invest Ophthalmol Vis Sci, 48, 5716, 10.1167/iovs.07-1023 Wood, 2002, Novel antiangiogenetic effect of the bisphosphonate compound zoledronic acid, J Pharmacol Exp Ther, 302, 1055, 10.1124/jpet.102.035295 Tanaka, 2007, Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for VEGF and osteopontin, Clin Cancer Res, 13, 816, 10.1158/1078-0432.CCR-06-2258 Kapitolá, 1998, Effect of pamidronate on blood flow in oophorectomized rats, Physiol Res, 47, 237 Migliorati, 2005, Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper, J Am Dent Assoc, 136, 1658, 10.14219/jada.archive.2005.0108 Ruggiero, 2006, Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102, 433, 10.1016/j.tripleo.2006.06.004 Magremanne, 2006, Bisphosphonates et osteo (chimio) nécrose maxillomandibulaire, Rev Stomatol Chir Maxillofac, 107, 423, 10.1016/S0035-1768(06)77081-4